R
Rapport Therapeutics, Inc. Common Stock
RAPP · NASDAQ · Healthcare · 2.3B
Price · close
$48.24
+0.82% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
4.7×
Enterprise value / EBITDAEV/EBITDA
-17.9×
Free cash flow yieldFCF yield
-3.9%
Return on equityROE
-23.0%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
0.3×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.